BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2559489)

  • 1. Time dependent factor IX inhibitor.
    Sarode R; Chauhan AP; Joseph M; Marwaha N; Sharma SK; Dash S
    Thromb Haemost; 1989 Dec; 62(4):1151. PubMed ID: 2559489
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired factor IX inhibitor in a patient with Christmas disease: case report.
    Riyat MS; Kasili EG; Omondi BE
    East Afr Med J; 1984 Feb; 61(2):159-62. PubMed ID: 6468323
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor IX-inhibitors. Report of two cases and a study of the biological, chemical and immunological properties of the inhibitors.
    Lechner K
    Thromb Diath Haemorrh; 1971 Jun; 25(3):447-59. PubMed ID: 5561957
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of venom of the central Asian cobra (Naja oxiana eich.) on the blood-coagulating system].
    Mitel'man LSh
    Biull Eksp Biol Med; 1966 Sep; 62(9):69-71. PubMed ID: 6012423
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia B+ with inhibitor.
    Ludwig M; Schwaab R; Olek K; Brackmann HH; Egli H
    Thromb Haemost; 1988 Apr; 59(2):340. PubMed ID: 3388303
    [No Abstract]   [Full Text] [Related]  

  • 11. [Circulating anticoagulants during hemophilia].
    Josso F; Cosson A; Gazengel C; Allain JP
    Rev Fr Transfus; 1972 Dec; 15(4):281-98. PubMed ID: 4659598
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coagulation factor IX inhibitor in hemophilia B].
    Lutze G; Mittler U; Presser HJ; Urbahn H
    Z Med Lab Diagn; 1990; 31(2):113-9. PubMed ID: 2343619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood platelets of hemophilia patients].
    Weibbbach G; Bührdel P; Domula M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H
    Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemophilia BM (abnormal factor IX in coagulation disorder) (author's transl)].
    Girolami A; Cella G; Patrassi G
    Haematologica; 1974 Mar; 59(1):91-108. PubMed ID: 4212668
    [No Abstract]   [Full Text] [Related]  

  • 17. Christmas factor inhibitor.
    Koepke JA; Shackelford E
    South Med J; 1968 Jul; 61(7):697-9. PubMed ID: 5664518
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of haemophilia B.
    Elödi S; Puskás E
    Thromb Diath Haemorrh; 1972 Dec; 28(3):489-95. PubMed ID: 4675270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.